Advertisement
Advertisement
U.S. Markets open in 11 mins
Advertisement
Advertisement
Advertisement
Advertisement

ASKA Pharmaceutical Holdings Co.,Ltd. (4886.T)

Tokyo - Tokyo Delayed Price. Currency in JPY
1,175.00-5.00 (-0.42%)
At close: 03:15PM JST
Advertisement
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Currency in JPY

Valuation Measures4

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 3/28/2023
Current
Market Cap (intraday)
N/A
Enterprise Value
N/A
Trailing P/E
N/A
Forward P/E
N/A
PEG Ratio (5 yr expected)
N/A
Price/Sales (ttm)
N/A
Price/Book (mrq)
N/A
Enterprise Value/Revenue
N/A
Enterprise Value/EBITDA
N/A

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 31,362.00
52 Week Low 3958.00
50-Day Moving Average 31,194.18
200-Day Moving Average 31,155.19

Share Statistics

Avg Vol (3 month) 346.15k
Avg Vol (10 day) 352.61k
Shares Outstanding 528.18M
Implied Shares Outstanding 6N/A
Float 8N/A
% Held by Insiders 128.60%
% Held by Institutions 122.86%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 416
Forward Annual Dividend Yield 41.35%
Trailing Annual Dividend Rate 314.00
Trailing Annual Dividend Yield 31.19%
5 Year Average Dividend Yield 4N/A
Payout Ratio 44.81%
Dividend Date 3N/A
Ex-Dividend Date 4Mar 30, 2023
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Mar 31, 2022
Most Recent Quarter (mrq)Dec 31, 2022

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)N/A
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)1,995.31
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)26.35B
EBITDA N/A
Net Income Avi to Common (ttm)N/A
Diluted EPS (ttm)71.84
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)N/A
Total Cash Per Share (mrq)N/A
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)N/A
Book Value Per Share (mrq)1,545.74

Cash Flow Statement

Operating Cash Flow (ttm)N/A
Levered Free Cash Flow (ttm)N/A
Advertisement
Advertisement